Tox21_300307

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

Chinese industrial activity revival at 98.6 percent, officials assure of API supplies

While the world feels the heat of the Covid-19 pandemic with the global pharmaceutical supply chain

COVID-19: India restricts drug exports amid rising prices of essential bulk drugs; FDA announces first drug shortage

Now that it has been established that the novel coronavirus is going to globally impact the drug s

Dr. Reddy’s faces penalties in the US; metformin found in American waters; Interpol seizes illicit medicines

 This week, Phispers brings to you the latest news from the world of pharma where Merck was fou